Global Neuroprotection Market Research Report 2019

Table of Contents

Executive Summary

1 Neuroprotection Market Overview

• 1.1 Product Overview and Scope of Neuroprotection
• 1.2 Neuroprotection Segment by Type
  • 1.2.1 Global Neuroprotection Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Free Radical Trapping Agents (Antioxidants)
  • 1.2.3 Glutamate Antagonists (Anti-Excitotoxic Agents)
  • 1.2.4 Apoptosis Inhibitors
  • 1.2.5 Anti-inflammatory Agents
  • 1.2.6 Neurotrophic Factors (NTFs)
  • 1.2.7 Metal Ion Chelators
  • 1.2.8 Stimulants
  • 1.2.9 Others
• 1.3 Neuroprotection Segment by Application
  • 1.3.1 Neuroprotection Consumption Comparison by Application (2014-2025)
  • 1.3.2 Prevention
  • 1.3.3 Treatment
• 1.3 Global Neuroprotection Market by Region
  • 1.3.1 Global Neuroprotection Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Neuroprotection Market Size
  • 1.4.1 Global Neuroprotection Revenue (2014-2025)
  • 1.4.2 Global Neuroprotection Production (2014-2025)

2 Global Neuroprotection Market Competition by Manufacturers

• 2.1 Global Neuroprotection Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Neuroprotection Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Neuroprotection Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Neuroprotection Production Sites, Area Served, Product Types
• 2.5 Neuroprotection Market Competitive Situation and Trends
  • 2.5.1 Neuroprotection Market Concentration Rate
  • 2.5.2 Neuroprotection Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Neuroprotection Production Market Share by Regions

• 3.1 Global Neuroprotection Production Market Share by Regions
• 3.2 Global Neuroprotection Revenue Market Share by Regions (2014-2019)
• 3.3 Global Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Neuroprotection Production
  • 3.4.1 North America Neuroprotection Production Growth Rate (2014-2019)
  • 3.4.2 North America Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Neuroprotection Production
  • 3.5.1 Europe Neuroprotection Production Growth Rate (2014-2019)
  • 3.5.2 Europe Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Neuroprotection Production (2014-2019)
  • 3.6.1 China Neuroprotection Production Growth Rate (2014-2019)
  • 3.6.2 China Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Neuroprotection Production (2014-2019)
  • 3.7.1 Japan Neuroprotection Production Growth Rate (2014-2019)
  • 3.7.2 Japan Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Neuroprotection Consumption by Regions

• 4.1 Global Neuroprotection Consumption by Regions
• 4.2 North America Neuroprotection Consumption (2014-2019)
• 4.3 Europe Neuroprotection Consumption (2014-2019)
• 4.4 China Neuroprotection Consumption (2014-2019)
• 4.5 Japan Neuroprotection Consumption (2014-2019)

5 Global Neuroprotection Production, Revenue, Price Trend by Type

• 5.1 Global Neuroprotection Production Market Share by Type (2014-2019)
• 5.2 Global Neuroprotection Revenue Market Share by Type (2014-2019)
• 5.3 Global Neuroprotection Price by Type (2014-2019)
• 5.4 Global Neuroprotection Production Growth by Type (2014-2019)

6 Global Neuroprotection Market Analysis by Applications

• 6.1 Global Neuroprotection Consumption Market Share by Application (2014-2019)
• 6.2 Global Neuroprotection Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Neuroprotection Business

• 7.1 Daiichi Sankyo Company
  • 7.1.1 Daiichi Sankyo Company Neuroprotection Production Sites and Area Served
  • 7.1.2 Neuroprotection Product Introduction, Application and Specification
  • 7.1.3 Daiichi Sankyo Company Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Eli Lilly and Company
  • 7.2.1 Eli Lilly and Company Neuroprotection Production Sites and Area Served
  • 7.2.2 Neuroprotection Product Introduction, Application and Specification
  • 7.2.3 Eli Lilly and Company Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Allergan
  • 7.3.1 Allergan Neuroprotection Production Sites and Area Served
  • 7.3.2 Neuroprotection Product Introduction, Application and Specification
  • 7.3.3 Allergan Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Dr. Reddy’s Laboratories
  • 7.4.1 Dr. Reddy’s Laboratories Neuroprotection Production Sites and Area Served
  • 7.4.2 Neuroprotection Product Introduction, Application and Specification
  • 7.4.3 Dr. Reddy’s Laboratories Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Teva Pharmaceutical
  • 7.5.1 Teva Pharmaceutical Neuroprotection Production Sites and Area Served
  • 7.5.2 Neuroprotection Product Introduction, Application and Specification
  • 7.5.3 Teva Pharmaceutical Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Novartis
  • 7.6.1 Novartis Neuroprotection Production Sites and Area Served
  • 7.6.2 Neuroprotection Product Introduction, Application and Specification
  • 7.6.3 Novartis Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 AstraZeneca
  • 7.7.1 AstraZeneca Neuroprotection Production Sites and Area Served
  • 7.7.2 Neuroprotection Product Introduction, Application and Specification
  • 7.7.3 AstraZeneca Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Astrocyte Pharmaceuticals
  • 7.8.1 Astrocyte Pharmaceuticals Neuroprotection Production Sites and Area Served
  • 7.8.2 Neuroprotection Product Introduction, Application and Specification
  • 7.8.3 Astrocyte Pharmaceuticals Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 F. Hoffmann-La Roche
  • 7.9.1 F. Hoffmann-La Roche Neuroprotection Production Sites and Area Served
  • 7.9.2 Neuroprotection Product Introduction, Application and Specification
  • 7.9.3 F. Hoffmann-La Roche Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Biogen
  • 7.10.1 Biogen Neuroprotection Production Sites and Area Served
  • 7.10.2 Neuroprotection Product Introduction, Application and Specification
  • 7.10.3 Biogen Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served

8 Neuroprotection Manufacturing Cost Analysis

• 8.1 Neuroprotection Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Neuroprotection
• 8.4 Neuroprotection Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Neuroprotection Distributors List
• 9.3 Neuroprotection Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Neuroprotection Market Forecast

• 11.1 Global Neuroprotection Production, Revenue Forecast
  • 11.1.1 Global Neuroprotection Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Neuroprotection Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Neuroprotection Price and Trend Forecast (2019-2025)
• 11.2 Global Neuroprotection Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Neuroprotection Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Neuroprotection Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Neuroprotection Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Neuroprotection Production, Revenue Forecast (2019-2025)
• 11.3 Global Neuroprotection Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Neuroprotection Consumption Forecast (2019-2025)
  • 11.3.2 Europe Neuroprotection Consumption Forecast (2019-2025)
  • 11.3.3 China Neuroprotection Consumption Forecast (2019-2025)
  • 11.3.4 Japan Neuroprotection Consumption Forecast (2019-2025)
• 11.4 Global Neuroprotection Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Neuroprotection Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List